Planta Med 2017; 83(14/15): 1207-1213
DOI: 10.1055/s-0043-113827
Natural Product Chemistry and Analytical Studies
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

A Validated Method for the Quality Control of Andrographis paniculata Preparations

Anastasia Karioti
1   Department of Chemistry, Building of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino (FI), Firenze, Italy
2   Department of Pharmacognosy-Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Patricia Timoteo
1   Department of Chemistry, Building of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino (FI), Firenze, Italy
,
Maria Camilla Bergonzi
1   Department of Chemistry, Building of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino (FI), Firenze, Italy
,
Anna Rita Bilia
1   Department of Chemistry, Building of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino (FI), Firenze, Italy
› Author Affiliations
Further Information

Publication History

received 19 January 2017
revised 30 May 2017

accepted 13 June 2017

Publication Date:
26 June 2017 (online)

Abstract

Andrographis paniculata is a herbal drug of Asian traditional medicine largely employed for the treatment of several diseases. Recently, it has been introduced in Europe for the prophylactic and symptomatic treatment of common cold and as an ingredient of dietary supplements. The active principles are diterpenes with andrographolide as the main representative. In the present study, an analytical protocol was developed for the determination of the main constituents in the herb and preparations of A. paniculata. Three different extraction protocols (methanol extraction using a modified Soxhlet procedure, maceration under ultrasonication, and decoction) were tested. Ultrasonication achieved the highest content of analytes. HPLC conditions were optimized in terms of solvent mixtures, time course, and temperature. A reversed phase C18 column eluted with a gradient system consisting of acetonitrile and acidified water and including an isocratic step at 30 °C was used. The HPLC method was validated for linearity, limits of quantitation and detection, repeatability, precision, and accuracy. The overall method was validated for precision and accuracy over at least three different concentration levels. Relative standard deviation was less than 1.13%, whereas recovery was between 95.50% and 97.19%. The method also proved to be suitable for the determination of a large number of commercial samples and was proposed to the European Pharmacopoeia for the quality control of Andrographidis herba.

Supporting Information

 
  • References

  • 1 World Health Organization. WHO Monographs on Selected Medicinal Plants. Geneva: World Health Organization; 2004: 12-24
  • 2 Kligler B, Ulbricht C, Basch E, Kirkwood CD, Abrams TR, Miranda M, Singh Khalsa KP, Giles M, Boon H, Woods J. Andrographis paniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration. Explore 2006; 2: 25-29
  • 3 Saxena RC, Singh R, Kumar P, Yadav SC, Negi MPS, Saxena VS, Joshua AJ, Vijayabalaji V, Goudar KS, Venkateshwarlu K, Amit A. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold (TM)) in patients with uncomplicated upper respiratory tract infection. Phytomedicine 2010; 17: 178-185
  • 4 European Medicines Agency. Assessment report on Andrographis paniculata Nees, folium. Committee on Herbal Medicinal Products 2014. Available at: 2017. http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2014/06/WC500168112.pdf Accessed January 15 2017
  • 5 Jayakumar T, Hsieh CY, Lee JJ, Sheu JR. Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid Based Complement Alternat Med 2013; 2013: 846740
  • 6 Subramanian R, Asmawi MZ, Sadikun A. A bitter plant with a sweet future? A comprehensive review of an oriental medicinal plant: Andrographis paniculata . Phytochem Rev 2012; 11: 39-75
  • 7 Wang M, Franz G. The role of the European Pharmacopoeia (Ph Eur) in quality control of traditional Chinese herbal medicine in European member states. World J Tradit Chin Med 2015; 1: 5-15
  • 8 Pholphana N, Rangkadilok N, Saehun J, Ritruechai S, Satayavivad J. Changes in the contents of four active diterpenoids at different growth stages in Andrographis paniculata (Burm.f.) Nees (Chuanxinlian). Chin Med 2013; 8: 1-12
  • 9 Ahmad M, Razak A, Akyirem Akowuah G, Asmawi Z, Zhar I. HPLC profile and antihyperglycemic effect of ethanol extracts of Andrographis paniculata in normal and streptozotocin-induced diabetic rats. J Nat Med 2007; 61: 422-429
  • 10 Jain DC, Gupta MM, Saxena S, Kumar S. LC analysis of hepatoprotective diterpenoids from Andrographis paniculata . J Pharm Biomed Anal 2000; 22: 705-709
  • 11 Palaniswamy UR. Effect of Light Intensity on the Pigment Composition and Oxalic Acid Concentrations in Kalamegh (Andrographis paniculata) Leaf. In: Palaniswamy UR, Craker LE Gardner ZE. eds. Proceedings of WOCMAP III, Vol. 6: Traditional Medicine & Nutraceuticals. Leuven: ISHS; 2005: 109-114
  • 12 Kumoro AC, Hasan M, Singh H. Effects of solvent properties on the Soxhlet extraction of diterpenoid lactones from Andrographis paniculata leaves. Science Asia 2009; 35: 306-309
  • 13 Plubrukarn A, Pinsuwan S, Ingkatawornwong S, Supavita T. Stability of andrographolide in powdered Andrographis herb under accelerated conditions. Planta Med 2006; 72: 954-956
  • 14 Lomlim L, Jirayupong N, Plubrukarn A. Heat-accelerated degradation of solid-state andrographolide. Chem Pharm Bull 2003; 51: 24-26
  • 15 Pholphana N, Rangkadilok N, Thongnest S, Ruchirawat S, Ruchirawat M, Satayavivad J. Determination and variation of three active diterpenoids in Andrographis paniculata (Burm.f.) Nees. J Phytochem Anal 2004; 15: 365-371
  • 16 Yang M, Wang Y, Kong L. Quantitative analysis of four major diterpenoids in Andrographis paniculata by 1H NMR and its application for quality control of commercial preparations. J Pharm Biomed Anal 2012; 70: 87-93
  • 17 Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 2007; 18: 2198-2204